Are Senolytic Agents Guilty of Overkill or Inappropriate Age Discrimination?-Reference-Cited by-同舟云学术

Are Senolytic Agents Guilty of Overkill or Inappropriate Age Discrimination?

Published:2023-02-21 Issue:8 Volume:147 Page:667-668
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Rabinovitch Marlene¹^ORCID

Affiliation:

1. BASE Initiative, Betty Irene Moore Children’s Heart Center, Lucile Packard Children’s Hospital, Vera Moulton Wall Center for Pulmonary Vascular Disease and Stanford Cardiovascular Institute, and Department of Pediatrics–Cardiology, Stanford University School of Medicine, CA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression

2. Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression

3. Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension

4. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension

5. Cellular senescence impairs the reversibility of pulmonary arterial hypertension

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib-based senomorphic therapy mitigates cardiomyocyte senescence in septic cardiomyopathy by inhibiting the JAK2/STAT3 signaling pathway;International Journal of Biological Sciences;2024

2. Chronic inflammation with microglia senescence at basal forebrain: impact on cholinergic deficit in Alzheimer’s brain haemodynamics;Brain Communications;2024

3. Clinical Impact and Mechanisms of Nonatherosclerotic Vascular Aging: The New Kid to Be Blocked;Canadian Journal of Cardiology;2023-12